A personal experience with SIRS and MODS

Critical Care Medicine

Volumn 24, Issue 8, 1996, Pages 1417-1418

  Bone, Roger C ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

cancer; dyspnea; interleukin 2; multiple organ dysfunction; systemic inflammatory response syndrome

Indexed keywords

FLUOROURACIL; INTERFERON; INTERLEUKIN 2;

ARTICLE; CANCER CHEMOTHERAPY; HUMAN; INFLAMMATION; METASTASIS; MULTIPLE ORGAN FAILURE; PARANEOPLASTIC SYNDROME; PRIORITY JOURNAL; SEPSIS;

EID: 0029828225     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199608000-00023     Document Type: Article

References (3)

1. Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee: American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20:864-874
2. Gaynor ER, Vitek L, Sticklin L, et al: The hemodynamic effects of treatment with interleukin-2 and lymphokine-activated killer cells. Ann Intern Med 1988; 109:953-958
3. Marshall JC, Cook DJ, Christou NV, et al: Multiple organ dysfunction score: A reliable descriptor of a complex clinical outcome. Crit Care Med 1995; 23: 1638-1652